Literature DB >> 7508443

A single amino acid substitution flanking the fourth calcium binding domain of alpha IIb prevents maturation of the alpha IIb beta 3 integrin complex.

D A Wilcox1, J L Wautier, D Pidard, P J Newman.   

Abstract

To define specific structural domains involved in the biosynthesis and processing of integrin subunits, we examined the biosynthesis of normal and mutated forms of the platelet-specific integrin alpha IIb beta 3. Platelet mRNA was isolated from a Glanzmann thrombasthenic patient who failed to express significant levels of the glycoprotein (GP) IIb-IIIa complex on the platelet surface. Sequence analysis of polymerase chain reaction-amplified platelet GPIIb mRNA revealed a Gly418-->Asp amino acid substitution in GPIIb. Gly418 is a highly conserved residue that flanks the fourth calcium binding domain of GPIIb. Cotransfection of Asp418 GPIIb and GPIIIa plasmid constructs into COS-7 cells resulted in the accumulation of a pre-GPIIb-IIIa complex that failed to reach the cell surface, in effect recreating the thrombasthenic phenotype. Pulse-chase and endoglycosidase studies demonstrated that the biosynthetic blockade occurred in a pre-Golgi compartment. Removal of the negatively charged carboxyl group of Asp418 GPIIb, creating Ala418 GPIIb, rescued intracellular transport and surface expression of the integrin complex. Mutagenesis of a homologous Gly within the integrin alpha subunit alpha v also resulted in the failure to express alpha v beta 3 on the cell surface. These results suggest that the presence of a small, uncharged amino acid 6-8 residues amino-terminal to the calcium coordination complex is crucial for the proper folding and maturation of integrin complexes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508443

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Demystified...adhesion molecule deficiencies.

Authors:  D Inwald; E G Davies; N Klein
Journal:  Mol Pathol       Date:  2001-02

2.  Clinical mutations in the L1 neural cell adhesion molecule affect cell-surface expression.

Authors:  H D Moulding; R L Martuza; S D Rabkin
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

Review 3.  The regulation of integrin function by divalent cations.

Authors:  Kun Zhang; JianFeng Chen
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

Review 4.  The integrin adhesome: from genes and proteins to human disease.

Authors:  Sabina E Winograd-Katz; Reinhard Fässler; Benjamin Geiger; Kyle R Legate
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04       Impact factor: 94.444

5.  Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.

Authors:  Y Jin; H C Dietz; R A Montgomery; W R Bell; I McIntosh; B Coller; P F Bray
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

6.  Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells.

Authors:  D A Wilcox; J C Olsen; L Ishizawa; M Griffith; G C White
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 7.  Platelet integrin alphaIIbbeta3-ligand interactions: what can we learn from the structure?

Authors:  T Kamata; Y Takada
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

8.  Diagnosis and Management of Inherited Platelet Disorders.

Authors:  Carl Maximilian Kirchmaier; Daniele Pillitteri
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

9.  Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association.

Authors:  D A Wilcox; C M Paddock; S Lyman; J C Gill; P J Newman
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 10.  Glanzmann thrombasthenia: state of the art and future directions.

Authors:  Alan T Nurden; Xavier Pillois; David A Wilcox
Journal:  Semin Thromb Hemost       Date:  2013-08-08       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.